What is the standard treatment for panic attacks?

Standard Treatment for Panic Attacks

Cognitive-behavioral therapy (CBT) specifically designed for panic disorder is the gold standard first-line treatment, either alone for mild-to-moderate presentations or combined with an SSRI (sertraline or escitalopram) for moderate-to-severe cases, with combination therapy demonstrating superior remission rates compared to monotherapy. 1, 2

First-Line Treatment Algorithm

Mild-to-Moderate Panic Disorder

• Start with CBT as monotherapy focusing on elimination of catastrophic misinterpretations of physical sensations and breaking the cycle of anticipatory anxiety, panic, and avoidance. 1, 3
• CBT typically consists of 12-15 sessions delivered individually or in group format. 3
• If CBT-trained therapists are unavailable, offer problem-solving approaches based on CBT principles for patients concerned about prior panic attacks. 4, 1
• Guided self-help CBT (approximately 9 brief sessions over 3-4 months with ~3 hours total therapist contact) can be considered when face-to-face therapy is inaccessible. 2

Moderate-to-Severe Panic Disorder

• Initiate combination treatment with CBT plus SSRI pharmacotherapy, which shows superior response and remission rates compared to either treatment alone. 1, 2
• Most primary care patients with panic disorder prefer psychological treatment over medication alone, making combination therapy particularly acceptable. 2

Pharmacotherapy Protocol

First-Line Medications

• Start with sertraline 25-50 mg daily or escitalopram 10 mg daily due to favorable efficacy and tolerability profiles. 1
• Begin with a subtherapeutic "test" dose to minimize initial anxiety or agitation, as panic patients are hypersensitive to physical sensations. 1
• Paroxetine (20-60 mg/day) is FDA-approved and highly effective, with 76% of patients receiving 40 mg/day becoming panic-attack-free in controlled trials compared to 44% on placebo. 5

Titration Strategy

• Titrate slowly at 1-2 week intervals for shorter half-life SSRIs (sertraline, escitalopram) or 3-4 week intervals for fluoxetine. 1
• Expect 4-6 weeks for clinically significant improvement and up to 12 weeks for maximal therapeutic effect. 1
• Assess treatment response within 4-6 weeks of reaching therapeutic dose using standardized symptom rating scales. 1

Second-Line Options

• Venlafaxine extended-release (SNRI) can be offered for patients who fail or cannot tolerate SSRIs, with demonstrated efficacy across anxiety disorders including panic. 4, 1, 2
• If inadequate response after 6-8 weeks at therapeutic dose, switch to a different SSRI or consider venlafaxine. 1

Treatment Duration and Maintenance

• Continue antidepressant treatment for 9-12 months after recovery to prevent relapse—this is critical as relapse is frequent with premature discontinuation. 4, 1, 2
• When discontinuing, taper SSRIs gradually to avoid discontinuation syndrome (dizziness, fatigue, nausea, sensory disturbances, anxiety). 1

Benzodiazepine Management: Critical Pitfalls

Why Benzodiazepines Should Be Avoided

• Benzodiazepines provide only short-term symptomatic relief and do not address the underlying pathology of panic disorder. 2
• Approximately 50% of patients continuously exposed for 12 months develop physiological dependence. 2
• Combination of in vivo exposure with high-dose benzodiazepines is counter-productive in the long term. 6

Absolute Contraindications

• Avoid benzodiazepines entirely in patients with substance use history, respiratory disorders, or elderly patients. 1

Tapering Protocol for Current Benzodiazepine Users

• Reduce the current dose by 10-25% every 1-2 weeks, aiming for complete discontinuation over a minimum of 6-12 months. 2
• Taper speed should be adjusted based on patient tolerance, with pauses permitted if withdrawal symptoms emerge. 2
• Abrupt cessation is contraindicated because it can precipitate seizures and potentially fatal outcomes. 2
• Deliver CBT concurrently during benzodiazepine taper, as this markedly improves taper success rates and overall treatment outcomes. 2, 7

Adjunctive Strategies

Beta-Blockers for Somatic Symptoms

• Atenolol 25 mg twice daily may be used short-term to control peripheral somatic symptoms (palpitations) while SSRI/SNRI titration is underway, but should be reassessed after 8-12 weeks and discontinued if core panic symptoms are controlled. 2

Acute Episode Management

• Apply psychological first aid principles including relaxation techniques and reassurance that symptoms are not life-threatening. 8
• Guide patients through box breathing (4-4-4-4 pattern: inhale 4 seconds, hold 4 seconds, exhale 4 seconds, hold 4 seconds) while seated upright with slight forward lean. 8
• Apply cooling to the face (cold compress or cool air) to reduce physiological arousal. 8
• Avoid psychological debriefing for recent traumatic events, as this may worsen outcomes. 4, 8

Safety Monitoring

SSRI/SNRI Monitoring

• Screen for emergent suicidal thoughts/behaviors in patients ≤24 years. 4, 1
• Watch for behavioral activation, hypomania/mania, and serotonin syndrome, especially if serotonergic agents are combined. 4, 1
• For SNRIs, regularly monitor blood pressure due to risk of sustained hypertension. 4

Benzodiazepine Withdrawal Monitoring

• Assess for anxiety, tremor, insomnia, sweating, tachycardia, and seizures. 2
• Schedule follow-up visits at least monthly during taper, with more frequent contacts during difficult phases. 2

Treatment-Resistant Cases

• If inadequate response after 6-8 weeks at therapeutic SSRI dose, switch to a different SSRI or consider SNRI (venlafaxine). 1
• Ensure CBT is being delivered by a skilled therapist following evidence-based protocols (Clark and Wells model or Heimberg model). 4
• Combination therapy (CBT + SSRI) should be prioritized for treatment-resistant cases, as it demonstrates superior outcomes. 1, 2

Long-Term Considerations

• Develop a written action plan for managing future episodes, teaching patients to recognize early warning signs (racing heart, tight chest, sense of impending doom) so they can implement coping strategies before symptoms escalate. 8
• Teach sensory grounding techniques: noticing environmental details (colors, textures, sounds), cognitive distractions (word games, counting backwards), or sensory-based distractors (flicking rubber band on wrist). 8
• Screen for comorbid depression, which occurs commonly with panic disorder and can influence treatment outcomes. 8